A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...

Novo Nordisk's U.S.-listed shares lost ground Friday after a study of the pharmaceutical firm’s latest obesity treatment ...

Novo Nordisk’s American depositary receipts tumbled almost 6% Friday after the drugmaker reported mixed results from a study of an experimental weight-loss pill. The pill, monlunabant, helped people ...

Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental ...

Sen. Bernie Sanders has been probing the high prices that Novo charges for Ozempic and Wegovy. Yesterday, he share that ...

Drew, a 36-year-old man from San Antonio, Texas, drove more than 250 miles to Mexico to buy cheap Ozempic to help him lose ...

Fake Ozempic adds to a glut of counterfeit pharmaceuticals that kill around a million people each year, according to the WHO.

Pharmaceutical companies, including Ozempic-maker Novo Nordisk, authenticate batches ... Identifying leaders of such a supply chain is a challenge. A New York woman, Isis Navarro Reyes, was ...

The news keeps getting better for the new GLP-1 weight-loss drugs fromEli Lilly and Novo Nordisk.

intensifying the company’s race with Novo Nordisk to develop longer-acting insulins. Lilly’s once-weekly insulin, efsitora alfa, reduced the A1C measure of blood sugar comparably to daily ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Novo Nordisk. Looking at options history for Novo Nordisk NVO we detected 9 trades. If we consider the specifics of ...

In the 1970s and 1980s, supply-side economics offered novel solutions to America’s ills, which included declining productivity, rising inflation, burdensome taxes, and a growing number of citizens ...